| Dr Rakesh Vardey, MD | |
|
7909 S 101st East Ave, Tulsa, OK 74133-3472 | |
| (918) 820-3499 | |
| (918) 820-3502 |
| Full Name | Dr Rakesh Vardey |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 15 Years |
| Location | 7909 S 101st East Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992016893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 9407455 (Kansas) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 35392 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
Biologists who study the malaria mosquito's 'nose' have found that it contains a secondary set of odor sensors that seem to be specially tuned to detect humans. The discovery could aid efforts to figure out how the insects target humans and develop a preference for them.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
A team of cancer specialists from OncoLink.org, the award-winning cancer Web-based resource of the Abramson Cancer Center of the University of Pennsylvania, has launched OncoLife, the first and only individualized plan-of-care based on the national Institute of Medicine's recommendations for adult cancer survivors.
A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."
› Verified 6 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
Biologists who study the malaria mosquito's 'nose' have found that it contains a secondary set of odor sensors that seem to be specially tuned to detect humans. The discovery could aid efforts to figure out how the insects target humans and develop a preference for them.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
A team of cancer specialists from OncoLink.org, the award-winning cancer Web-based resource of the Abramson Cancer Center of the University of Pennsylvania, has launched OncoLife, the first and only individualized plan-of-care based on the national Institute of Medicine's recommendations for adult cancer survivors.
A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."
› Verified 6 days ago
| Entity Name | Lightyear Health Clinic Oklahoma Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053093054 PECOS PAC ID: 8820444391 Enrollment ID: O20231020000267 |
News Archive
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
Biologists who study the malaria mosquito's 'nose' have found that it contains a secondary set of odor sensors that seem to be specially tuned to detect humans. The discovery could aid efforts to figure out how the insects target humans and develop a preference for them.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
A team of cancer specialists from OncoLink.org, the award-winning cancer Web-based resource of the Abramson Cancer Center of the University of Pennsylvania, has launched OncoLife, the first and only individualized plan-of-care based on the national Institute of Medicine's recommendations for adult cancer survivors.
A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rakesh Vardey, MD 6600 S Yale Ave Ste 1400, Tulsa, OK 74136-3331 Ph: (888) 247-0125 | Dr Rakesh Vardey, MD 7909 S 101st East Ave, Tulsa, OK 74133-3472 Ph: (918) 820-3499 |
News Archive
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
Biologists who study the malaria mosquito's 'nose' have found that it contains a secondary set of odor sensors that seem to be specially tuned to detect humans. The discovery could aid efforts to figure out how the insects target humans and develop a preference for them.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
A team of cancer specialists from OncoLink.org, the award-winning cancer Web-based resource of the Abramson Cancer Center of the University of Pennsylvania, has launched OncoLife, the first and only individualized plan-of-care based on the national Institute of Medicine's recommendations for adult cancer survivors.
A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."
› Verified 6 days ago
Mr. Anil Kumar Reddy, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9725 East 79th Street, Suit A, Tulsa, OK 74133 Phone: 918-252-0112 Fax: 918-252-0103 | |
Alyxandria Calvert, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4157 S Harvard Ave Ste 101, Tulsa, OK 74135 Phone: 918-949-4390 | |
Abigail Rose Cutter, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2300 E 14th St Ste 104, Tulsa, OK 74104 Phone: 918-982-6800 | |
Kelsey Michelle Harshman, MOT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7031 S Indianapolis Ave, Tulsa, OK 74136 Phone: 918-510-7089 | |
Dr. Bobby N Daniel, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4833 S Sheridan Rd, Suite 414, Tulsa, OK 74145 Phone: 918-488-9992 Fax: 918-488-9993 | |
Carrie Leigh Moss, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1724 S Harvard Ave, Tulsa, OK 74112 Phone: 918-250-7093 Fax: 918-250-9976 | |
Mr. Gregory Scott Argabright, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8303 E 81st St, Suite F, Tulsa, OK 74133 Phone: 918-249-0020 Fax: 918-249-0019 |